Therabreath Plaque Control
NDC 10237-259, CETYLPYRIDINIUM CHLORIDE, rinse, from Church & Dwight Co., Inc..
- Product NDC
- 10237-259
- Status
- Listed
- Labeler
- Church & Dwight Co., Inc.
- Dosage form
- RINSE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10237-259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETYLPYRIDINIUM CHLORIDE.015 mg/20mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10237-259-16 | 10237025916 | 473 mL in 1 BOTTLE, PLASTIC (10237-259-16) |
| 10237-259-26 | 10237025926 | 2 BOTTLE, PLASTIC in 1 BOX (10237-259-26) / 473 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10237-259 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10237-259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10237-259. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.